Request Deal Involvement
Charterhouse-backed SERB Pharmaceuticals completed the acquisition of reactive skin decontamination lotion assets from Emergent Biosolutions for $75m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Freshfields Bruckhaus Deringer
legal advisors
Mayer Brown
financial advisors
Rothschild & Co
or
Principals
bidder
CHARTERHOUSE CAPITAL PARTNERS
bidder
SERB PHARMACEUTICALS
target
EMERGENT BIOSOLUTIONS (REACTIVE SKIN DECONTAMINATION LOTION ASSETS)
vendor
EMERGENT BIOSOLUTIONS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite